ObjectiveThis study aimed to investigate the value of interim whole-body dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) Patlak parameters for predicting prognosis patients with diffuse large B-cell lymphoma. To estimate predictive 18F-FDG PET/CT parameter 2-year progression-free survival (PFS) and overall (OS).MethodsThis reports findings 67 lym...

Abstract Background Infective endocarditis is a challenging diagnosis that usually requires cardiovascular image confirmation as part of the approach. 18F-FDG PET/CT an imaging technique more sensible for prosthetic valve when echocardiography inconclusive. Case Summary We present case 35-year-old man who had previous Bentall-De Bono procedure four years prior included biological, INC-type, loc...

Positron emission tomography using 18F-fluorodeoxyglucose (FDG-PET) has been successfully evaluated in the management of non-Hodgkin's lymphoma (NHL).1-3 Histological transformation (HT) of indolent lymphoma is a dramatic event that occurs in 5-10% of the patients and carries a dismal prognosis.4,5 Previous studies prove that indolent lymphoma entities show a lower FDG uptake when compared with...

Positron Emission Tomography - Computed (PET-CT) has been used to diagnose malignancy before surgery. However, there may be an increase in 18F-fluorodeoxyglucose (FDG) uptake PET scans benign conditions, leading a false-positive diagnosis of and unnecessary This PET-CT investigation is expensive not without risk, including radiation drug or contrast hypersensitivity. Although variable uterine u...

Abstract Funding Acknowledgements Type of funding sources: None. Background 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) can detect arterial inflammation in individuals with atherosclerosis, but the associations among different vascular territories for 18F-FDG uptake are not known. Purpose We explored any possible correlation between quantified by PET aorta, carotid arter...

An operationalized workflow paradigm is presented and validated with pilot subject data. This approach is reproducible with a high concordance rate between individual readers (kappa 0.73 [confidence interval 0.59-0.87; P=<0.0001]) using a 5-point scale to assess [18F] labeled fluorodeoxyglucose metabolic activity in lymphomatous lesions. These results suggest an operationally practical 5-point ...

Asymptomatic skeletal muscle metastasis in non-small cell lung cancer is a rare event particularly when it is detected at initial staging. This report describes how whole body imaging with [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET)-computed tomography (CT) detected a solitary asymptomatic metastasis to the gluteus maximus muscle in a potentially resectable case of non-smal...

In the present review we reported the value of 18F-fluorodeoxyglucose (FDG) PET/CT in face of uterine cancer, in terms of sensitivity, specificity and accuracy. Moreover, we made a comparison with the other imaging techniques currently used to evacuate these tumors including contrast-enhanced CT, contrast enhanced-MRI and transvaginal ultrasonography. FDG PET/CT has been reported to be of parti...

Recent studies showing excellent sensitivity of [18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET)-CT for detecting marrow involvement in patients with Hodgkin lymphoma (HL)[1-3] and diffuse large B-cell lymphoma (DLBCL)[4] have led some to claim that bone marrow biopsy (BMB) is obsolete. The argument is that the low number of patients “upstaged” by positive BMB no longer justifi...